Cost-utility and budget impact analysis of biosimilar trastuzumab for early-stage HER2-positive breast cancer in Thailand: an updated evaluation supporting expanded access

Related articles

1. Effectiveness of Using a Drug Cost Calculator to Improve Patients’ Understanding of Drug Costs in Advanced Breast Cancer: A Multicenter, Randomized Controlled Trial

   This article has 14 authors:

   1. Sayaka Kuba
   2. Hiroki Moriuchi
   3. Kosho Yamanouch
   4. Shigeto Maeda
   5. Megumi Matsumoto
   6. Hiroshi Yano
   7. Masahiro Oikawa
   8. Michi Morita
   9. Momoko Akashi
   10. Aya Tanaka
   11. Ryota Otsubo
   12. Kengo Kanetaka
   13. Keitaro Matsumoto
   14. Susumu Eguchi

2. Efficacy and safety of anti-VEGF/VEGFR monotherapy and combination with immune checkpoint inhibitors for advanced or metastatic renal cell carcinoma: a network meta-analysis

   This article has 5 authors:

   1. Min Duan
   2. Yanjun Liu
   3. Kexin Qiao
   4. Zuojing Li
   5. Dongsheng Zong

3. Impact of PSA nadir on outcomes in metastatic hormone sensitive prostate cancer. An individual patient data meta-analysis

   This article has 13 authors:

   1. Laura Pappalardo
   2. Mattia Alberto Di Civita
   3. Danila De Angelis
   4. Marco Stellato
   5. Luca Zacco
   6. Simone Rota
   7. Eleonora Gusmaroli
   8. Valentina Guadalupi
   9. Iolanda Speranza
   10. Michela Roberto
   11. Elena Verzoni
   12. Giuseppe Procopio
   13. Daniele Santini